The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era

Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but ar...

Full description

Bibliographic Details
Published in:Canadian Journal of Gastroenterology and Hepatology
Main Authors: Sonya A MacParland, Marc Bilodeau, Jason Grebely, Julie Bruneau, Curtis Cooper, Marina Klein, Selena M Sagan, Norma Choucha, Louise Balfour, Frank Bialystok, Mel Krajden, Jennifer Raven, Eve Roberts, Rodney Russell, Michael Houghton, D Lorne Tyrrell, Jordan J Feld
Format: Other/Unknown Material
Language:English
Published: Canadian Journal of Gastroenterology and Hepatology 2014
Subjects:
Online Access:https://doi.org/10.1155/2014/704919
id fthindawi:oai:hindawi.com:10.1155/2014/704919
record_format openpolar
spelling fthindawi:oai:hindawi.com:10.1155/2014/704919 2023-05-15T16:16:44+02:00 The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era Sonya A MacParland Marc Bilodeau Jason Grebely Julie Bruneau Curtis Cooper Marina Klein Selena M Sagan Norma Choucha Louise Balfour Frank Bialystok Mel Krajden Jennifer Raven Eve Roberts Rodney Russell Michael Houghton D Lorne Tyrrell Jordan J Feld 2014 https://doi.org/10.1155/2014/704919 en eng Canadian Journal of Gastroenterology and Hepatology https://doi.org/10.1155/2014/704919 Copyright © 2014 Canadian Association for the Study of the Liver. Commentary 2014 fthindawi https://doi.org/10.1155/2014/704919 2019-05-26T05:16:43Z Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario. Other/Unknown Material First Nations Hindawi Publishing Corporation British Columbia ENVELOPE(-125.003,-125.003,54.000,54.000) Canada Canadian Journal of Gastroenterology and Hepatology 28 9 481 487
institution Open Polar
collection Hindawi Publishing Corporation
op_collection_id fthindawi
language English
description Hepatitis C virus (HCV) currently infects approximately 250,000 individuals in Canada and causes more years of life lost than any other infectious disease in the country. In August 2011, new therapies were approved by Health Canada that have achieved higher response rates among those treated, but are poorly tolerated. By 2014/2015, short-course, well-tolerated treatments with cure rates >95% will be available. However, treatment uptake is poor due to structural, financial, geographical, cultural and social barriers. As such, ‘Barriers to access to HCV care in Canada’ is a crucial topic that must be addressed to decrease HCV disease burden and potentially eliminate HCV in Canada. Understanding how to better care for HCV-infected individuals requires integration across multiple disciplines including researchers, clinical services and policy makers to address the major populations affected by HCV including people who inject drugs, baby boomers, immigrants and Aboriginal and/or First Nations people. In 2012, the National CIHR Research Training Program in Hepatitis C organized the 1st Canadian Symposium on Hepatitis C Virus (CSHCV) in Montreal, Quebec. The 2nd CSHCV was held in 2013 in Victoria, British Columbia. Both symposia were highly successful, attracting leading international faculty with excellent attendance leading to dialogue and knowledge translation among attendees of diverse backgrounds. The current article summarizes the 3rd CSHCV, held February 2014, in Toronto, Ontario.
format Other/Unknown Material
author Sonya A MacParland
Marc Bilodeau
Jason Grebely
Julie Bruneau
Curtis Cooper
Marina Klein
Selena M Sagan
Norma Choucha
Louise Balfour
Frank Bialystok
Mel Krajden
Jennifer Raven
Eve Roberts
Rodney Russell
Michael Houghton
D Lorne Tyrrell
Jordan J Feld
spellingShingle Sonya A MacParland
Marc Bilodeau
Jason Grebely
Julie Bruneau
Curtis Cooper
Marina Klein
Selena M Sagan
Norma Choucha
Louise Balfour
Frank Bialystok
Mel Krajden
Jennifer Raven
Eve Roberts
Rodney Russell
Michael Houghton
D Lorne Tyrrell
Jordan J Feld
The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
author_facet Sonya A MacParland
Marc Bilodeau
Jason Grebely
Julie Bruneau
Curtis Cooper
Marina Klein
Selena M Sagan
Norma Choucha
Louise Balfour
Frank Bialystok
Mel Krajden
Jennifer Raven
Eve Roberts
Rodney Russell
Michael Houghton
D Lorne Tyrrell
Jordan J Feld
author_sort Sonya A MacParland
title The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_short The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_full The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_fullStr The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_full_unstemmed The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
title_sort 3rd canadian symposium on hepatitis c virus: expanding care in the interferon-free era
publisher Canadian Journal of Gastroenterology and Hepatology
publishDate 2014
url https://doi.org/10.1155/2014/704919
long_lat ENVELOPE(-125.003,-125.003,54.000,54.000)
geographic British Columbia
Canada
geographic_facet British Columbia
Canada
genre First Nations
genre_facet First Nations
op_relation https://doi.org/10.1155/2014/704919
op_rights Copyright © 2014 Canadian Association for the Study of the Liver.
op_doi https://doi.org/10.1155/2014/704919
container_title Canadian Journal of Gastroenterology and Hepatology
container_volume 28
container_issue 9
container_start_page 481
op_container_end_page 487
_version_ 1766002584672272384